Recent Finacing
Recent Raise
Duality Biologics develops novel-modality oncology and autoimmune therapeutics, advancing a ~10‑candidate bispecific antibody and ADC pipeline, a proprietary ADC platform with global IP, and IND-stage programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
